Baldo, F.; Simeone, R.; Marcuzzi, A.; Grasso, A.G.; Vidimari, R.; Ciriello, F.; Zanon, D.; Maestro, A.; Barbi, E.; Maximova, N.
Post-Irradiation Hyperamylasemia Is a Prognostic Marker for Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Pediatric Population: A Retrospective Single-Centre Cohort Analysis. J. Clin. Med. 2021, 10, 3834.
https://doi.org/10.3390/jcm10173834
AMA Style
Baldo F, Simeone R, Marcuzzi A, Grasso AG, Vidimari R, Ciriello F, Zanon D, Maestro A, Barbi E, Maximova N.
Post-Irradiation Hyperamylasemia Is a Prognostic Marker for Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Pediatric Population: A Retrospective Single-Centre Cohort Analysis. Journal of Clinical Medicine. 2021; 10(17):3834.
https://doi.org/10.3390/jcm10173834
Chicago/Turabian Style
Baldo, Francesco, Roberto Simeone, Annalisa Marcuzzi, Antonio Giacomo Grasso, Rossella Vidimari, Francesca Ciriello, Davide Zanon, Alessandra Maestro, Egidio Barbi, and Natalia Maximova.
2021. "Post-Irradiation Hyperamylasemia Is a Prognostic Marker for Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Pediatric Population: A Retrospective Single-Centre Cohort Analysis" Journal of Clinical Medicine 10, no. 17: 3834.
https://doi.org/10.3390/jcm10173834
APA Style
Baldo, F., Simeone, R., Marcuzzi, A., Grasso, A. G., Vidimari, R., Ciriello, F., Zanon, D., Maestro, A., Barbi, E., & Maximova, N.
(2021). Post-Irradiation Hyperamylasemia Is a Prognostic Marker for Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Pediatric Population: A Retrospective Single-Centre Cohort Analysis. Journal of Clinical Medicine, 10(17), 3834.
https://doi.org/10.3390/jcm10173834
